Literature DB >> 9410612

[Cytokines and cytokine receptors in mouth mucosa of immune suppressed patients].

H Schliephake1, K Redecker, R Schmelzeisen, H Maschek.   

Abstract

In vitro studies on epithelial cells suggest that cyclosporin (CsA) inhibits a pathway of production of IL-6, which is mediated by TNF alpha and E. coli. The aim of the present immunohistochemical study was therefore to evaluate the content and location of cytokines and cytokine receptors in the oral mucosa of 10 patients with CsA medication. Ten patients without immunosuppression served as controls. Specimens were procured during surgical treatment and processed by paraffin embedding and as cryosections. Expression of TNF alpha, IL-1 beta and IL-6-receptor was present both in the epithelial layer and the submucosal tissues, but did not differ very greatly between patients with CsA therapy and the controls. IL-6, however, displayed a positive reaction only in the control group, while it was invisible in the group of patients with CsA medication. The immunohistochemical findings of the present study suggest that there may be a lack of mucosal expression of IL-6 under CsA medication. With regard to the broad spectrum of possible effects of proinflammatory cytokines and their multiple interactions, the functional relevance of these findings merits further investigation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9410612     DOI: 10.1007/BF03043525

Source DB:  PubMed          Journal:  Mund Kiefer Gesichtschir        ISSN: 1432-9417


  11 in total

1.  Identification and characterization of the rat intestinal epithelial cell (IEC-18) interleukin-1 receptor.

Authors:  D B Sutherland; G W Varilek; G A Neil
Journal:  Am J Physiol       Date:  1994-05

2.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

3.  Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist.

Authors:  C Simón; A Frances; G N Piquette; I el Danasouri; G Zurawski; W Dang; M L Polan
Journal:  Endocrinology       Date:  1994-02       Impact factor: 4.736

4.  Cyclosporin A does not inhibit IL-1 alpha-induced epithelial cell IL-6 secretion.

Authors:  S Hedges; W Agace; M Svensson; C Svanborg
Journal:  Scand J Immunol       Date:  1993-05       Impact factor: 3.487

5.  Differential regulation of granulocyte-macrophage colony-stimulating factor gene expression in human corneal cells by pro-inflammatory cytokines.

Authors:  C L Cubitt; R N Lausch; J E Oakes
Journal:  J Immunol       Date:  1994-07-01       Impact factor: 5.422

6.  Transforming growth factor-beta and IL-1 beta act in synergy to enhance IL-6 secretion by the intestinal epithelial cell line, IEC-6.

Authors:  D W McGee; K W Beagley; W K Aicher; J R McGhee
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

7.  Novel production of interleukin-1 receptor antagonist peptides in normal human cornea.

Authors:  M C Kennedy; J T Rosenbaum; J Brown; S R Planck; X Huang; C A Armstrong; J C Ansel
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

8.  Immunohistological determination of interleukin-1 beta in inflamed human gingival epithelium.

Authors:  G Hillmann; B Hillmann; W Geurtsen
Journal:  Arch Oral Biol       Date:  1995-04       Impact factor: 2.633

9.  Interleukin-1 binds to specific receptors on human bronchial epithelial cells and upregulates granulocyte/macrophage colony-stimulating factor synthesis and release.

Authors:  M Marini; M Soloperto; M Mezzetti; A Fasoli; S Mattoli
Journal:  Am J Respir Cell Mol Biol       Date:  1991-06       Impact factor: 6.914

10.  Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta.

Authors:  A E Postlethwaite; R Raghow; G P Stricklin; H Poppleton; J M Seyer; A H Kang
Journal:  J Cell Biol       Date:  1988-02       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.